Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | Valuation Score | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $155.68 | $9.60 | 1,521.20% | 389.20x | -55.01x | 83.39x | 5.66x | 7.36x | -$603.00k | -0.01% | $778.64M | 28.68 | $4.05B | 226.45 | |
| TGTX | TG THERAPEUTICS INC | $13.91 | $4.88 | 185.31% | 154.56x | -20.76x | 8.45x | 13.38x | 1.11x | -$31.41M | -1.59% | $160.50M | 1.13 | $2.16B | 83.56 | |
| GMAB | GENMAB A | $27.46 | $21.65 | 26.84% | 28.31x | 16.64x | 7.57x | 3.94x | 0.59x | $1.02B | 5.62% | $4.60B | 6.96 | $16.09B | N/A | |
| INCY | INCYTE CORP | $51.18 | $63.97 | -20.00% | 19.17x | 8.62x | 3.10x | 2.21x | 0.36x | $464.00M | 4.05% | $5.19B | 23.21 | $8.31B | 9.04 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $82.17 | $34.39 | 138.94% | 92.33x | 29.24x | 6.38x | 3.13x | 0.97x | $62.57M | 0.41% | $4.95B | 26.36 | $15.84B | 51.03 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $28.93 | $43.85 | -34.02% | 13.33x | 7.49x | 2.96x | 3.52x | 0.32x | $219.08M | 12.73% | $466.99M | 7.85 | $1.52B | 6.88 | |
| CORT | CORCEPT THERAPEUTICS INC | $22.21 | $16.30 | 36.24% | 21.77x | 15.86x | 4.77x | 4.54x | 0.73x | $126.90M | 5.52% | $506.71M | 4.89 | $2.16B | 19.85 | |
| MDXG | MIMEDX GROUP INC | $6.25 | $5.76 | 8.41% | 15.61x | 124.90x | 2.26x | 6.43x | 0.61x | $24.79M | 3.41% | $142.72M | 1.23 | $883.85M | 27.13 | |
| HALO | HALOZYME THERAPEUTICS INC | $38.46 | $47.87 | -19.67% | 18.06x | 9.43x | 6.12x | 58.20x | 0.37x | $373.28M | 7.36% | $83.81M | 0.64 | $6.26B | 13.85 | |
| RPRX | ROYALTY PHARMA PLC | $28.11 | $41.84 | -32.81% | 11.07x | 6.98x | 5.34x | 1.67x | 0.35x | $2.98B | 23.65% | $10.08B | 22.53 | $22.45B | 16.98 | |
| VNDA | VANDA PHARMACEUTICALS INC | $4.48 | $1.65 | 171.76% | 112.00x | 16.59x | 1.33x | 0.47x | 1.10x | $12.42M | 4.82% | $544.91M | 9.50 | $128.95M | 13.79 | |
| TECH | BIO-TECHNE CORP | $62.66 | $22.21 | 182.08% | 44.44x | 26.00x | 8.62x | 5.02x | 1.52x | $225.39M | 2.28% | $1.96B | 12.46 | $10.28B | 27.55 | |
| EXEL | EXELIXIS INC | $23.53 | $16.22 | 45.04% | 36.20x | 14.61x | 4.09x | 3.15x | 0.65x | $292.86M | 3.91% | $2.26B | 7.12 | $7.06B | 22.62 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $107.43 | $183.41 | -41.43% | 16.40x | 4.43x | 1.77x | 1.79x | 0.26x | $1.07B | 15.71% | $3.74B | 59.05 | $10.96B | 8.96 | |
| PBYI | PUMA BIOTECHNOLOGY INC | $4.88 | $7.14 | -31.69% | 10.61x | 7.75x | 0.98x | 4.40x | 0.37x | $26.87M | 11.68% | $53.44M | 1.13 | $262.16M | 5.52 | |
| BNTX | BIONTECH SE | $86.71 | $77.34 | 12.12% | 20.61x | 18.29x | 4.97x | 0.94x | 0.56x | $5.07B | 24.60% | $22.01B | 92.57 | $8.67B | 5.72 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $1.78 | $40.38 | -95.59% | 2.44x | 0.58x | 0.31x | 0.28x | 0.02x | $10.68M | 8.93% | $433.43M | 6.45 | -$46.03M | -0.83 | |
| CPRX | CATALYST PHARMACEUTICALS INC | $14.68 | $7.55 | 94.38% | 21.91x | 16.31x | 3.92x | 4.46x | 1.33x | $143.37M | 9.19% | $387.88M | 3.65 | $1.60B | 12.50 | |
| NVO | NOVO NORDISK A S | $125.79 | $19.45 | 546.82% | 46.28x | 51.87x | 16.78x | 36.57x | 9.72x | $12.10B | 2.13% | $15.51B | 3.44 | $569.15B | 34.16 | |
| UTHR | UNITED THERAPEUTICS CORP | $235.95 | $180.11 | 31.00% | 11.21x | 12.23x | 4.74x | 1.86x | 1.28x | $747.60M | 6.77% | $5.98B | 127.88 | $10.60B | 7.64 | |
| REGN | REGENERON PHARMACEUTICALS INC | $890.68 | $266.18 | 234.62% | 24.04x | 21.92x | 7.25x | 3.76x | 4.96x | $3.88B | 4.08% | $25.97B | 243.42 | $97.74B | 20.82 | |
| VRTX | VERTEX PHARMACEUTICALS INC | $397.70 | $89.18 | 345.94% | 28.31x | 29.26x | 10.38x | 5.84x | 11.53x | $3.34B | 3.26% | $17.58B | 68.22 | $93.08B | 20.21 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.